Highway Holdings Increases Ownership in Myanmar Manufacturing Entity to 84 Percent
Apr 18, 2017 12:31 pm UTC| Business
HONG KONG, April 18, 2017 -- Highway Holdings Limited (Nasdaq:HIHO) today announced the company has increased its ownership interest to 84 percent at its Myanmar subsidiary. Terms were not disclosed. The Myanmar...
Highway Holdings Increases Ownership in Myanmar Manufacturing Entity to 84 Percent
Apr 18, 2017 12:31 pm UTC| Business
HONG KONG, April 18, 2017 -- Highway Holdings Limited (Nasdaq:HIHO) today announced the company has increased its ownership interest to 84 percent at its Myanmar subsidiary. Terms were not disclosed. The Myanmar...
3D Signatures Announces Relocation to MaRS Discovery District in Toronto
Apr 18, 2017 12:31 pm UTC| Business
WINNIPEG, Manitoba, April 18, 2017 -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), is pleased to announce that the Company will relocate its corporate offices to the MaRS Discovery...
3D Signatures Announces Relocation to MaRS Discovery District in Toronto
Apr 18, 2017 12:31 pm UTC| Business
WINNIPEG, Manitoba, April 18, 2017 -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), is pleased to announce that the Company will relocate its corporate offices to the MaRS Discovery...
Mondelēz International Changes North American Leadership
Apr 18, 2017 12:30 pm UTC| Business
Roberto Marques to leave the companyTim Cofer assumes interim leadership of the North American region DEERFIELD, Ill., April 18, 2017 -- Mondelēz International today announced that Roberto Marques, EVP and President,...
MyoKardia Appoints David Meeker, M.D., to Board of Directors
Apr 18, 2017 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., April 18, 2017 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...
Apr 18, 2017 12:30 pm UTC| Business
SOLANA BEACH, Calif., April 18, 2017 -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company has reached an...